1. Home
  2. LGND vs UA Comparison

LGND vs UA Comparison

Compare LGND & UA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • UA
  • Stock Information
  • Founded
  • LGND 1987
  • UA 1996
  • Country
  • LGND United States
  • UA United States
  • Employees
  • LGND N/A
  • UA N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • UA Apparel
  • Sector
  • LGND Health Care
  • UA Consumer Discretionary
  • Exchange
  • LGND Nasdaq
  • UA Nasdaq
  • Market Cap
  • LGND 2.0B
  • UA 2.6B
  • IPO Year
  • LGND 1992
  • UA N/A
  • Fundamental
  • Price
  • LGND $102.19
  • UA $6.31
  • Analyst Decision
  • LGND Strong Buy
  • UA Strong Buy
  • Analyst Count
  • LGND 8
  • UA 1
  • Target Price
  • LGND $144.71
  • UA $9.00
  • AVG Volume (30 Days)
  • LGND 118.3K
  • UA 3.9M
  • Earning Date
  • LGND 05-08-2025
  • UA 05-13-2025
  • Dividend Yield
  • LGND N/A
  • UA N/A
  • EPS Growth
  • LGND N/A
  • UA N/A
  • EPS
  • LGND N/A
  • UA N/A
  • Revenue
  • LGND $181,488,000.00
  • UA $5,164,310,000.00
  • Revenue This Year
  • LGND $17.68
  • UA N/A
  • Revenue Next Year
  • LGND $18.69
  • UA $3.03
  • P/E Ratio
  • LGND N/A
  • UA N/A
  • Revenue Growth
  • LGND 53.40
  • UA N/A
  • 52 Week Low
  • LGND $77.43
  • UA $4.62
  • 52 Week High
  • LGND $129.90
  • UA $10.62
  • Technical
  • Relative Strength Index (RSI)
  • LGND 44.63
  • UA 58.43
  • Support Level
  • LGND $98.90
  • UA $5.95
  • Resistance Level
  • LGND $103.17
  • UA $6.41
  • Average True Range (ATR)
  • LGND 3.05
  • UA 0.27
  • MACD
  • LGND -0.27
  • UA 0.03
  • Stochastic Oscillator
  • LGND 31.94
  • UA 66.47

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About UA Under Armour Inc. Class C

Under Armour develops, markets, and distributes athletic apparel, footwear, and accessories in North America, Asia-Pacific, Europe, and elsewhere. Consumers of its performance-based clothing and shoes include professional and amateur athletes, sponsored college and professional teams, and people with active lifestyles. The company sells merchandise through direct-to-consumer, including e-commerce and more than 400 combined factory house and brand house stores, and wholesale channels. The Baltimore-based company was founded in 1996 and is led by controlling shareholder Kevin Plank.

Share on Social Networks: